In the original article, there was a mistake in the Supplementary Table named Table S3 AUCs, Sensitivity, Specificity of cox2, β-catenin and wnt3a in predicting diagnosis, myometrial invasion, vessel invasion, lymph node metastasis, and poor prognosis as published. The specificity of wnt3a in serum for myometrial invasion is 0.316 and the p value is 0.010. The corrected Supplementary Table S3 appears below.
Table S3
| Item | AUCs | Sensitivity | Specificity | 95% CI | P | |
|---|---|---|---|---|---|---|
| Diagnosis | Cox2 expression | 0.931 | 0.918 | 0.812 | 0.882–0.981 | 0 |
| β-catenin expression | 0.933 | 0.902 | 0.750 | 0.886–0.980 | 0 | |
| Cox2 in serum | 0.887 | 0.951 | 0.719 | 0.805–0.968 | 0 | |
| Wnt3a in serum | 0.931 | 0.967 | 0.812 | 0.873–0.981 | 0 | |
| Myometrial invasion | Cox2 expression | 0.732 | 0.826 | 0.500 | 0.605–0.860 | 0.003 |
| β-catenin expression | 0.692 | 0.783 | 0.526 | 0.556–0.6827 | 0.013 | |
| Cox2 in serum | 0.590 | 0.913 | 0.237 | 0.437–0.744 | 0.240 | |
| Wnt3a in serum | 0.698 | 0.913 | 0.316 | 0.566–0.830 | 0.010 | |
| Vessel invasion | Cox2 expression | 0.702 | 0.739 | 0.632 | 0.567–0.837 | 0.009 |
| β-catenin expression | 0.763 | 0.783 | 0.526 | 0.619–0.906 | 0.001 | |
| Cox2 in serum | 0.696 | 0.739 | 0.632 | 0.558–0.834 | 0.011 | |
| Wnt3a in serum | 0.757 | 0.783 | 0.632 | 0.631–0.884 | 0.001 | |
| Lymph node metastasis | Cox2 expression | 0.692 | 0.800 | 0.549 | 0.537–0.847 | 0.056 |
| β-catenin expression | 0.693 | 0.700 | 0.686 | 0.522–0.864 | 0.055 | |
| Cox2 in serum | 0.732 | 0.800 | 0.627 | 0.596–0.869 | 0.021 | |
| Wnt3a in serum | 0.711 | 0.700 | 0.765 | 0.517–0.905 | 0.036 | |
| Prognosis | Cox2 expression | 0.789 | 0.850 | 0.659 | 0.676–0.902 | 0 |
| β-catenin expression | 0.869 | 0.850 | 0.854 | 0.767–0.971 | 0 | |
| Cox2 in serum | 0.752 | 0.800 | 0.732 | 0.623–0.881 | 0.002 | |
| Wnt3a in serum | 0.711 | 0.750 | 0.585 | 0.561–0.861 | 0.008 |
AUCs, Sensitivity, Specificity of cox2, β-catenin and wnt3a in predicting diagnosis, myometrial invasion, vessel invasion, lymph node metastasis, and poor prognosis.
An author was incorrectly labeled as Haiyan Liang1, as she is the co-correspondence author. The correct label is Haiyan Liang1*.
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
cyclooxygenase-2, β-catenin, wnt3a, endometrial cancer, prognostic marker, diagnostic marker
Citation
Deng L, Liang H and Han Y (2020) Corrigendum: Cyclooxygenase-2 and β-Catenin as Potential Diagnostic and Prognostic Markers in Endometrial Cancer. Front. Oncol. 10:582704. doi: 10.3389/fonc.2020.582704
Received
13 July 2020
Accepted
10 September 2020
Published
03 November 2020
Volume
10 - 2020
Edited and reviewed by
Giuseppe Vizzielli, Catholic University of the Sacred Heart, Italy
Updates
Copyright
© 2020 Deng, Liang and Han.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Lin Deng flora1085@163.comHaiyan Liang 13611311360@139.com
This article was submitted to Women's Cancer, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.